Open AccessOverview of the Pharmacological Management of Osteoporosis in Postmenopausal Women
Author(s) -
N. Sherly Shulamite,
B. Pragna Malavika,
P. Aravinda Swami
Publication year - 2021
Publication title -
journal of pharmaceutical research international
Language(s) - English
Resource type - Journals
ISSN - 2456-9119
DOI - 10.9734/jpri/2021/v33i41a32321
Subject(s) - medicine , denosumab , teriparatide , osteoporosis , observational study , postmenopausal women , physical therapy , bone mineral
Aim: The aim of the study is to assess the Pharmacological management of osteoporosis in postmenopausal women.
Objective: The purpose of this study is to evaluate the treatment of osteoporosis in postmenopausal women.
Methodology: This is an observational prospective study, carried out in a tertiary care hospital.
Results: A total of 300 postmenopausal women were enrolled in the study. The mean ± standard deviation, of the age of postmenopausal women included in this study was 55.5 ± 5.0 years. 68.1% were prescribed with the combinational therapy of Teriparatide+Bisphosphonates. 39.2% of subjects were using acetaminophen for pain.
Conclusion: Antiresorptive drugs (hormonal therapy, bisphosphonates, and denosumab) and, the anabolic agents (teriparatide) are commonly prescribed, in this study it is obvious that Sequential Therapy is highly prevailing in the clinical practice, with 68.1%.